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between	 sex	 and	 the	 performance	 of	 coronary	 angiography,	 reperfusion	 and	
revascularisation.
Results:	Among	STEMI/NC	ACS,	men	had	higher	probability	of	performing	coronary	
angiography	 than	 women	 (adjusted	 OR	=	1.64,	 95%	 CI:	 1.11-	2.44),	 while	 among	
NSTEACS	 patients	 there	was	 no	 significant	 difference	 by	 sex	 (adjusted	OR	=	1.26,	
95%	CI:	0.99-	1.62).	In	patients	who	underwent	coronary	angiography,	there	was	no	
difference	in	proportion	of	women	and	men	submitted	to	revascularisation,	regardless	




bility when compared with men to be submitted to coronary angiography. There was 
no	difference	in	performance	of	reperfusion	and	revascularisation	by	sex.
1  | INTRODUCTION
In	 the	 last	decades,	one	of	 the	major	determinants	of	 the	decrease	
in coronary heart disease (CHD) mortality in Europe, in women and 
men,	was	a	more	effective	access	to	coronary	angiography.1 However, 
recent	data	show	that	men	with	an	acute	coronary	syndrome	(ACS)	
are	still	more	likely	to	undergo	an	invasive	approach.2 In Portugal, be-
tween	2010	and	2013,	16.5%	of	patients	with	non-	ST-	elevation	myo-
cardial	 infarction,	mostly	women,	were	 treated	with	 a	 conservative	
strategy.3	Although	from	2002	to	2013	a	three-	fold	 increase	 in	pri-
mary	angioplasty	was	observed,	the	proportion	of	women	remained	
approximately	the	same	(24.5%	and	26.2%,	respectively).4 These data 
were	obtained	from	registries	that	included	patients	admitted	to	car-
diology departments, but not to other departments, and to hospitals 
offering	 differentiated	 care,	 and	 therefore	might	 not	 represent	 the	
national	 trends	 in	 the	 invasive	 diagnostic-	therapeutic	 approach	 of	
women	and	men	with	ACS.
The	decrease	in	CHD	mortality	in	Portugal	was	found	to	be	greater	
among women compared to men,5	the	result	of	effective	primary	and/
or secondary prevention measures implemented in this group. Changes 
in	the	major	cardiovascular	risk	factors	in	Portugal	contributed	signifi-
cantly more to the CHD decrease among women than among men, 
mainly	due	to	 lifestyle	changes,	as	 the	effect	of	 risk	 factor	 lowering	
treatment was small and similar between sexes.1 Improvements in sex 
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differences	in	discharge	medications	after	an	ACS	as	well	as	in	drug-	
eluting stents use might also have contributed to these results.6,7
Sex	and	gender	differences	concerning	ACS	are	described	in	sev-
eral	 categories,	 namely	 risk	 assessment,	 disease	 awareness,	 comor-
bidities, presentation, treatment and outcomes,8 contributing to a 
potential	 different	 access	 to	health	 care	between	women	and	men.	
Real-	world	 data	 about	 sex	 differences	 in	 management	 of	 ACS	 pa-
tients, treated in hospitals with diverse characteristics, and consider-








2.1 | Study design and sample selection
Data	 for	 this	 study	 were	 collected	 within	 the	 framework	 of	 the	
EURopean	Hospital	Benchmarking	by	Outcomes	in	acute	coronary	syn-
drome Processes (EURHOBOP) project, a collaborative, multicentre and 
multinational	retrospective	study	of	patients	consecutively	hospitalised	
with	a	discharge	diagnosis	of	ACS	from	70	hospitals	in	7	European	coun-
tries (Finland, France, Germany, Greece, Italy, Portugal, and Spain),9,10 
For	the	current	analysis	we	used	data	from	patients	admitted	to	the	10	
Portuguese	 hospitals,	which	were	 selected	 to	 cover	 different	 regions	
from	the	mainland	country,	from	north	to	south	and	west	to	east	and	
including both coastal and interior regions, urban and rural populations. 
Furthermore,	 these	 hospitals	 had	 different	 characteristics,	 regarding	
population	served,	 facilities,	 technical	and	human	resources,	and	spe-
cialisation levels. These diverse settings were selected with the purpose 
of	 seeking	 representativeness	 of	 the	 general	ACS	population.	Overall	
five	hospitals	had	a	catheterisation	laboratory,	three	had	a	cardiac	sur-
gery	department,	in	one	patients	with	ACS	were	admitted	to	the	internal	
medicine department, as the hospital had no cardiology department or 
cardiologists,	four	were	university	hospitals,	the	number	of	beds	ranged	
from	280	 to	1124	and	 the	populations	 served	 ranged	 from	 less	 than	
300 000 to more than 700 000 people. Each hospital contributed with 
approximately 300 consecutive patients discharged between 2008 and 
2010	with	diagnosis	of	ACS	(International	Classification	of	Diseases	10th	
revision:	 I.21.0-	I	 21.9	 and	 I.20.0).	 From	 3009	ACS	 patients	 included,	
those	with	missing	data	on	the	type	of	ACS	were	excluded	(n	=	68).
2.2 | Procedures and data collection
With	 the	use	of	 standardised	 forms,	 trained	 investigators	extracted	
data	from	discharge	letters,	emergency	room	records	and	laboratory	
systems.	When	necessary,	 different	 sources	were	 cross-	checked	 to	
ensure	completeness	and	quality	of	the	 information.	 Information	on	
type	of	ACS,	 demographic	 characteristics,	 previous	medical	 history,	
admission data, procedures used during hospitalisation, severity 
indicators and complications during hospitalisation, including vital 
status	and	in-	hospital	medication	(the	main	classes	of	recommended	
drugs	for	patients	with	ACS)11,12 was extracted.
2.3 | Definition of variables and data analysis
Patients	with	left	bundle	branch	block	were	defined	as	non-	classifiable	
(NC)	 ACS	 (NC	ACS)	 and	 analysed	with	 STEMI	 patients	 (STEMI/NC	
ACS	group).
The	management	was	 considered	 invasive	 if	 coronary	 angiogra-
phy	was	performed.	Reperfusion	was	defined	as	either	thrombolysis	
or primary percutaneous coronary intervention; revascularisation, ei-
ther as percutaneous coronary intervention (PCI) or coronary artery 
bypass	 graft	 (CABG).	 Anaemia	 was	 defined	 as	 haemoglobin	 below	
12	g/dL	for	females	and	below	13	g/dL	for	males13 and renal impair-
ment	was	 subdivided	 in	 two	 groups:	 estimated	 glomerular	 filtration	












• Several studies have suggested that women with acute 
coronary	syndrome	are	more	likely	to	be	treated	with	a	
conservative strategy than men.
•	 Studies	 in	 different	 settings	 support	 that	 disparities	 in	








•	 Women	with	 ST-elevation	 acute	myocardial	 infarction/
non-classifiable	(left	bundle	branch	block)	acute	coronary	
syndrome, but not with non-ST-elevation acute coronary 
syndrome,	 were	 less	 frequently	 submitted	 to	 coronary	
angiography than men.
•	 No	differences	in	reperfusion	or	revascularisation	among	
those managed invasively were observed between 
women	and	men	for	the	whole	spectrum	of	acute	coro-
nary syndrome presentations.
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The	 proportions	 of	 prescription	 of	main	 classes	 of	 drugs	 during	








statin].	 For	 simple	 antiplatelet	 therapy	 (aspirin	 or	 clopidogrel),	 hae-
moglobin	below	10	g/dL	for	females	and	below	11	g/dL	for	males	at	
admission was considered a contraindication. For double antiplatelet 
therapy,	 besides	 a	 low	value	of	haemoglobin	 at	 admission,	 previous	
atrial	 fibrillation	 or	 being	 on	 oral	 anticoagulation	 at	 admission	were	
considered	 also	 contraindications.	 A	 systolic	 blood	 pressure	 lower	






cular	 risk	 factors,	 cardiovascular	 history,	 complications	 at	 admission	
and	angiographic	coronary	disease	(the	latter	for	the	revascularisation	
models	only).	In	the	univariate	analysis,	we	identified	which	variables	
were associated with management (P-	value<.15),	using	logistic	regres-
sion.	Within	each	group	mentioned	above,	variables	with	a	significant	
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in three hospitals lower proportions were observed; the lowest was 
24.7%	in	a	hospital	without	catheterisation	 laboratory	and	cardiol-
ogy	ward	(Table	1).	Only	in	one	hospital,	the	proportion	of	patients	
with	 previous	 history	 of	 myocardial	 infarction,	 PCI	 or	 CABG	was	
below	20%.	The	proportions	of	patients	with	 complications	 at	 ad-
mission	varied	 between	38.7%	 and	61.1%	between	hospitals.	The	
two	hospitals	with	the	lowest	and	the	highest	proportions	of	com-
plications at admission were similar in characteristics, namely were 
tertiary hospitals, with catheterisation laboratory, located in the 
coast and covering an urban predominantly population. In all hos-
pitals,	most	patients	had	severe	angiographic	coronary	disease	of	at	
least	of	one	vessel.	The	proportion	of	patients	who	had	at	least	one	
in-	hospital	 complication	 varied	 between	 7.3%	 in	Hospital	 de	 Faro	
and	23.7%	in	Centro	Hospitalar	do	Porto.	The	in-	hospital	mortality	
varied	 between	 0.8%	 in	 Centro	Hospitalar	Alto	Ave	 and	 14.6%	 in	











prevalent	 in	 women,	 who	 presented	 less	 often	 with	 severe	 angio-






3.7%	 of	 men	 with	 NSTEACS	 died	 during	 hospitalisation	 (P	=	.159),	
while	among	STEMI/NC	ACS	patients,	 in-	hospital	death	was	signifi-
cantly	 higher	 among	women	 than	men	 (17.9%	vs	 8.3%,	P<.001,	 re-
spectively) (Table 2).
3.2 | Management
Compared with patients treated conservatively, women and men 
with	NSTEACS	or	STEMI/NC	ACS	who	were	treated	invasively	more	
frequently	had	prescription	of	 the	several	 recommended	classes	of	
drugs	 during	 hospitalisation.	 Patients	 with	 STEMI/NC	 ACS,	 both	
women and men, managed conservatively were the subgroup who 
had	 the	 lowest	 prescription	 of	 recommended	 drugs	 during	 hospi-
talisation	(Figure	1).	Women	with	NSTEACS	managed	conservatively	
were	 significantly	 less	 likely	 to	 receive	 statins	 (54.2%	 vs	 64.7%,	
P	=	.009)	 and	 5-	drug	 treatment	 (20.7%	 vs	 34.3%,	 P = .002) than 
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men	 with	 NSTEACS	 managed	 conservatively;	 while	 women	 with	
NSTEACS	managed	invasively	were	more	likely	to	receive	an	ACEi/
ARB	 during	 hospitalisation	 than	men	with	 the	 same	 diagnosis	 and	




An	 invasive	 strategy	 was	 less	 frequent	 in	 women,	 regardless	
of	the	type	of	ACS	(56.6%	vs	71.8%,	P<.001,	and	62.5%	vs	80.8%,	




[OR]	 1.64,	 95%	 confidence	 interval	 [95%	 CI]	 1.11-	2.44).	 Among	
patients	 performing	 coronary	 angiography,	 52.7%	 and	 76.5%	 of	
women	and	58.3%	and	81.6%	of	men	with	NSTEACS	and	STEMI/
NC	ACS,	 respectively,	were	 submitted	 to	 revascularisation.	 There	
was	 no	 difference	 by	 sex	 in	 the	 odds	 of	 revascularisation	 in	 both	
TABLE  2 Baseline	characteristics	of	patients	with	different	types	of	acute	coronary	syndrome,	by	sex
NSTEACS STEMI/NC ACS
Women Men P Women Men P
634 (36.1) 1123 (63.9) 341 (28.8) 843 (71.2)
Age	(y),	mean	(SD) 73.2 (11.8) 65.7	(12.7) <.001 73.2 (13.6) 63.1	(13.5) <.001
Cardiovascular	risk	factors
Hypertension 500	(78.9) 751	(66.9) <.001 246 (72.1) 461	(54.7) <.001
Diabetes 275	(43.4) 351	(31.3) <.001 104	(30.5) 206 (24.4) .032
Dyslipidaemia 327	(51.6) 634	(56.5) .049 146 (42.8) 384	(45.6) .391
Current	smoking 34	(5.4) 306 (27.3) <.001 29	(8.5) 323 (38.3) <.001
Cardiovascular history
Previous	MI,	PCI	or	CABG 156	(24.6) 382 (34.0) <.001 46	(13.5) 122	(14.5) .661
Previous HF 87 (13.7) 101 (9.0) .002 45	(13.2) 34 (4.0) <.001
Previous	AF 55	(8.7) 72 (6.4) .078 29	(8.5) 35	(4.2) .003
Chronic	renal	failure 214 (33.8) 236 (21.0) <.001 97	(28.5) 136 (16.1) <.001
Previous	stroke 67 (10.6) 98 (8.7) .204 31 (9.1) 52	(6.2) .074
Peripheral artery disease 21 (3.3) 59	(5.3) .061 4 (1.2) 20 (2.4) .185
Complications at admission
Pulmonary	oedema	or	shock 9 (1.4) 8 (0.7) .146 10 (2.9) 23 (2.7) .847
Anaemia 238 (39.0) 300 (28.0) <.001 115	(35.6) 156	(19.3) <.001
Renal impairment (GFR)
30	to	<60	ml/min/1.73	m2 264 (43.1) 257	(23.9) 136 (42.4) 182 (22.7)
<30	ml/min/1.73	m2 79 (12.9) 91	(8.5) <.001 44 (13.7) 38 (4.7) <0.001
Angiographic	coronary	disease
Normal/Mild 67 (18.8) 59	(7.5) 15	(7.1) 19 (2.8)
Moderate 15	(4.2) 34 (4.3) 5	(2.4) 11 (1.6)
Severe—1 vessel 117 (32.9) 254	(32.2) 105	(50.0) 347	(51.3)
Severe—2 vessels 78 (21.9) 227 (28.8) 48 (22.9) 180 (26.6)





97	(15.3) 126 (11.2) .014 67 (19.7) 116 (13.8) .011
In- hospital death 32	(5.1) 41 (3.7) .159 61 (17.9) 70 (8.3) <.001
Total may not add to 2941 due to missing data.
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NSTEACS	 (0.84,	 0.61-	1.14)	 and	 STEMI/NC	ACS	 (1.00,	 0.62-	1.62)	
after	 adjustment	 (Table	3).	 More	 men	 than	 women	 with	 STEMI/
NC	ACS	 had	 reperfusion	 therapy	 (67.9%	 vs	 49.3%,	 respectively).	
However,	 this	 significant	crude	association	between	male	sex	and	
reperfusion	(2.17,	1.68-	2.84)	was	explained	after	multivariable	ad-
justment	 (1.33,	0.96-	1.84).	 In	 the	sensitivity	analysis,	NC	ACS	pa-
tients (n = 163) were excluded and the results were comparable to 
primary results (Table 4).
4  | DISCUSSION
This	 study	 shows	 that	 women	 with	 STEMI/NC	 ACS,	 but	 not	 with	
NSTEACS,	were	 less	 frequently	 submitted	 to	 coronary	 angiography	





without ST- elevation according to sex and management approach.
*P-value <.05
ACEi, angiotensin converng enzyme inhibitor; ARB, angiotensin receptor blocker; NSTEACS, non-ST elevaon acute coronary syndrome; 
STEMI/NC ACS, ST-elevaon myocardial infarcon/non-classifiable acute coronary syndrome
3-drug treatment (aspirin or clopidogrel) and beta-blocker and stan
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described, but remain poorly understood.10,15,16 In Portugal, between 
1981	 and	 2012,	 relative	 declines	 of	 CHD	mortality	 indicators	were	
different	by	geographic	region;	consistent	decreases	in	mortality	rates	





the observed in the whole EURHOBOP sample.10	 Approximately	
40%	of	patients	of	our	sample	were	diagnosed	with	STEMI/NC	ACS;	
data	 from	 the	 Portuguese	 Registry	 of	 Acute	 Coronary	 Syndrome	





higher than the observed in other countries.10	For	both	types	of	ACS	
data	from	the	overall	EURHOBOP	study	showed	that	Portugal	had	
one	of	the	highest	proportions	of	in-	hospital	events	and	mortality,	
even	 after	 exhaustive	 model	 adjustment.10	 Analysing	 data	 sepa-
rately	by	sex	and	type	of	ACS,	we	were	able	to	identify	a	subgroup	of	
patients	with	particularly	high	risk	of	in-	hospital	death,	women	with	
STEMI/NC	ACS	 (17.9%).	 Considering	 prescription	 of	 drugs	 during	
hospitalisation,	higher	differences	were	observed	between	patients	
with	different	management	approaches,	than	between	women	and	








n (%) Crude OR (95% CI)
Adjusted OR 








1.94	(1.59-	2.39) 1.26 (0.99- 1.62) Patient characteristics: age, dyslipidaemia, 
history	of	heart	failure,	stroke,	renal	impair-






1.26 (0.98- 1.62) 0.84 (0.61- 1.14) Patient characteristics: age, renal impairment at 
admission, angiographic coronary disease
Hospital	characteristics:	presence	of	catheterisa-








2.53	(1.91-	3.34) 1.64 (1.11- 2.44) Patient characteristics: age, dyslipidaemia, 
smoking,	history	of	myocardial	infarction,	









2.17 (1.68- 2.81) 1.33 (0.96- 1.84) Patient characteristics: age, dyslipidaemia, 
smoking,	history	of	myocardial	infarction,	
percutaneous intervention or coronary artery 
bypass	surgery,	of	heart	failure,	renal	
impairment and anaemia at admission
Hospital	characteristics:	presence	of	catheterisa-













aPercutaneous coronary intervention and/or coronary artery bypass surgery among those submitted to coronary angiography.
bThrombolysis or primary percutaneous coronary intervention.






comorbidities, are more prone to atypical presentations, thrombus 
formation	and	plaque	erosion,	but	less	prone	to	suffer	from	severe	
obstructive coronary artery disease.18,19	Women	encounter	 longer	
delays	between	 the	onset	of	 symptoms	and	 first	medical	 contact,	





counselling	and	 referral	 to	cardiovascular	 testing	between	women	
and	men,	and	not	by	differential	attitudes,	behaviours	and	decisions	
of	female	patients.21














pitals with higher specialisation levels were included in this registry. 
In	NSTEACS	patients,	only	 those	with	unstable	 angina,	without	 risk	







After	 adjusting	 for	 several	 of	 these	 factors,	 no	difference	 in	perfor-
mance	of	coronary	angiography	between	sexes	was	observed	 in	the	
NSTEACS	group,	representing	an	improvement	in	the	sex	equality	of	
access to evidence- based treatment.2




presenting	more	 than	12	hours	 after	 symptoms	onset	 is	more	 con-
troversial.12	The	use	of	reperfusion	therapy	in	our	sample	is	similar	to	
the	observed	in	ProACS	covering	years	2002-	2008	(62.5%	vs	61.9%,	
respectively),23	but	 lower	than	the	observed	 in	 the	second	phase	of	
the	 ProACS	 (84.8%).17	 Implementation	 of	 a	 pre-	hospital	 fast-	track	
network	 in	 Portugal	 improved	 reperfusion	 rates	 in	 STEMI	 patients,	








higher delays being expected among women. The subjective experi-
ence	of	symptoms	 influences	patients’	attitudes	 in	help	seeking	and	






n (%) Crude OR (95% CI)






























aThrombolysis or primary percutaneous coronary intervention.
bPercutaneous coronary intervention and/or coronary artery bypass surgery among those submitted to coronary angiography.
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In	both	 types	of	ACS,	no	differences	 in	 revascularisation	among	
those managed invasively were observed between women and men. 
This	also	represents	a	sex-	gap	improvement	in	access	to	care.	When	
the	 decision	 to	 proceed	 to	 an	 invasive	 approach	 is	made,	 risks	 and	
benefits	 of	 revascularisation	 have	 already	 been	 evaluated.26 In our 
cohort,	 a	 significant	proportion	of	patients	of	both	 sexes,	especially	
in	 the	NSTEACS	 group	was	 not	 revascularised.	 Clinical	 and/or	 ana-
tomic reasons such as non- obstructive coronary heart disease, or 








information	on	 socioeconomic	 status,	 clinical	presentation	and	 time	
delays was available.
5  | CONCLUSIONS
In	 a	 real-	life	 setting,	women	with	STEMI/NC	ACS	are	 less	 likely	
than	men	 to	 be	managed	 invasively.	 No	 sex	 differences	 in	 rep-
erfusion	 and	 revascularisation	 were	 observed	 in	 both	 types	 of	
ACS,	which	represents	an	important	achievement,	and	help	to	un-
derstand the greater declines in CHD mortality observed among 
women compared to men in Portugal. Further improvements are 
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